about
Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis StudyMetabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.Prospects for the development of epigenetic drugs for CNS conditions.Gender differences in mood stabilizer medications prescribed to Veterans with serious mental illness.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Off-label use of sodium valproate for schizophrenia
@ast
Off-label use of sodium valproate for schizophrenia
@en
Off-label use of sodium valproate for schizophrenia
@nl
type
label
Off-label use of sodium valproate for schizophrenia
@ast
Off-label use of sodium valproate for schizophrenia
@en
Off-label use of sodium valproate for schizophrenia
@nl
prefLabel
Off-label use of sodium valproate for schizophrenia
@ast
Off-label use of sodium valproate for schizophrenia
@en
Off-label use of sodium valproate for schizophrenia
@nl
P2093
P2860
P1433
P1476
Off-label use of sodium valproate for schizophrenia
@en
P2093
Charna Ashkenazy
Einav Horowitz
Haya Grinvald-Fogel
Irit Moscona-Hurvitz
Lisa Carroll Bergman
Racheli Magnezi
P2860
P304
P356
10.1371/JOURNAL.PONE.0092573
P407
P577
2014-01-01T00:00:00Z